Should children be deprived of the benefits of flouroquinolones?

dc.contributor.authorDe Silva, D.G.H.
dc.date.accessioned2016-01-14T08:39:38Z
dc.date.available2016-01-14T08:39:38Z
dc.date.issued1994
dc.identifier.citationThe Ceylon Medical Journal, 39(2)pp.113-114
dc.identifier.urihttps://dl.nsf.gov.lk/handle/1/20436
dc.publisherThe Sri Lanka Medical Association:Colombo
dc.subjectMedical Sciences
dc.subjectAntimicrobial chemotheraphy
dc.subjectDrug toxicology
dc.subjectArthropathy
dc.subjectPaediatrics
dc.subjectQuinolone nalidixic
dc.subjectPharmacology
dc.titleShould children be deprived of the benefits of flouroquinolones?
dc.typeArticle

Files